GPC5 gene amplification and protein overexpression are observed in malignant lymphoma, non-small cell lung cancer (NSCLC), breast cancer, and rhabdomyosarcoma [[15], [16], [17], [18]]. Here, GPC5 is linked to non-small cell lung carcinoma.